| 1 | 5838-00-6 | Dimethyl(trifluoromethyl)malonate | C6H7F3O4 | 200.11 | | |
| 2 | 5838-12-0 | Borazine, 1,3,5-tris(2,6-dimethylphenyl)-2,4,6-trihydroxy- | C24H30B3N3O3 | 440.95 | | |
| 3 | 5838-34-6 | Sodium 1-undecanesulfonate | C11H23NaO3S | 258.35 | >300°C | Solubility in water is almost transparent. |
| 4 | 5838-37-9 | 1-(3-chlorophenyl)-3,5-bis(4-chlorophenyl)-4,5-dihydro-1H-pyrazole | C21H15Cl3N2 | 401.7162 | | |
| 5 | 5838-43-7 | AVERYTHRIN | C20H18O6 | 354.35 | | |
| 6 | 5838-57-3 | 1H-Benzimidazole,2-(3-butenyl)-(9CI) | C11H12N2 | 172.23 | | |
| 7 | 5838-75-5 | N-[4-(1,3-benzoxazol-2-yl)phenyl]-2-(4-bromophenoxy)acetamide | C44H82O11S2 | 851.25 | | |
| 8 | 5838-79-9 | 1,3-Oxathiane, 2,2-bis(phenylmethyl)- | C18H20OS | 284.42 | | |
| 9 | 5838-99-3 | 1H-Pyrazole, 1-(4-bromo-3-chlorophenyl)-3-(4-bromophenyl)-4,5-dihydro- | C15H11Br2ClN2 | 414.52 | | |
| 10 | 58380-00-0 | DP-11 | C11H17NO3 | 211.25758 | | |
| 11 | 58380-11-3 | 2-bromo-5-hydroxybenzoic acid | C7H5BrO3 | 217.02 | 185 °C (decomp) | |
| 12 | 58380-12-4 | Propanedioic acid, 2-[(2-bromophenyl)methyl]- | C10 H9 Br O4 | 273.08 | 139-140 °C | |
| 13 | 58380-13-5 | Benzeneacetic acid, 2,4,6-tribromo- | C8H5Br3O2 | 372.84 | | |
| 14 | 58380-23-7 | 2-[2-ETHOXY-1-(ETHOXYCARBONYL)-2-OXOETHYL]NICOTINIC ACID | C13H15NO6 | 281.26 | | |
| 15 | 58380-24-8 | 8-[2-ethoxy-1-(ethoxycarbonyl)-2-oxoethyl]-1-naphthoic acid | C18H18O6 | 330.33192 | | |
| 16 | 58380-40-8 | Benzaldehyde, 4-hydroxy-2,3-dimethyl- | C9H10O2 | 150.17 | | |
| 17 | 58380-63-5 | 10-Phenyldecanoic acid ethyl ester | C18H28O2 | 276.41 | | |
| 18 | 58380-73-7 | 5-mercaptouridine 5'-diphosphate | C9H14N2O12P2S | 436.23 | | |
| 19 | 58380-75-9 | 5-mercaptouridylic acid | C9H13N2O9PS | 356.25 | | |
| 20 | 58380-76-0 | 8-azabicyclo[3.2.1]octane-8-carbonyl chloride | C8H12ClNO | 173.64 | | |
| 21 | 58380-92-0 | 2,2,3,4,4,4-HEXAFLUORO-1,1-DIMETHYLBUTANOL | C6H8F6O | 210.12 | | |
| 22 | 58380-93-1 | 3-(2,2,3,4,4,4-HEXAFLUORO-BUTOXY)-PROPIONITRILE | C7H7F6NO | 235.13 | | |
| 23 | 58381-05-8 | 5-Fluoro-2-methoxy-4-pyridinamine | C6H7FN2O | 142.13 | | |
| 24 | 58381-10-5 | 2(1H)-Pyridinone, 4-amino-5-fluoro-1-methyl- | C6H7FN2O | 142.13 | | |
| 25 | 58381-22-9 | Diethyl 4-nitro-1H-pyrazole-3,5-dicarboxylate | C9H11N3O6 | 257.2 | | |
| 26 | 58381-23-0 | 1-O-Acetyl-2,3,5-tri-O-benzyl-D-ribofuranose | C28H30O6 | 462.53 | | |
| 27 | 58381-39-8 | 1H-Pyrazole-3,5-dicarboxamide, 1-β-D-ribofuranosyl- | C10H14N4O6 | 286.24 | | |
| 28 | 58381-76-3 | 2,2'-(ethylene)bis[5-[[4-[bis(2-hydroxyethyl)amino]-6-methoxy-1,3,5-triazin-2-yl]amino]benzenesulphonic] acid, compound with 2,2',2''-nitrilotriethanol (1:2) | C36H55N11O15S2 | 946.0166 | | |
| 29 | 58381-87-6 | 2,2'-disulfanediylbis(4-nitroaniline) | C12H10N4O4S2 | 338.36 | | |
| 30 | 583810-76-8 | Pyrazolo[3,4-b]azepine, 1,4,5,6,7,8-hexahydro-1-methyl-3-(1-methyl-2-piperidinyl)- (9CI) | C14H24N4 | 248.37 | | |
| 31 | 583810-87-1 | Pyrazolo[3,4-b]azepine, 1,4,5,6,7,8-hexahydro-1-methyl-3-(1-piperidinylmethyl)- (9CI) | C14H24N4 | 248.37 | | |
| 32 | 583811-38-5 | Pyrazolo[3,4-b]azepine, 1,4,5,6,7,8-hexahydro-1-methyl-3-(1-methyl-4-piperidinyl)- (9CI) | C14H24N4 | 248.37 | | |
| 33 | 583811-42-1 | Pyrazolo[3,4-b]azepine, 1,4,5,6,7,8-hexahydro-1-methyl-3-(1-methyl-3-piperidinyl)- (9CI) | C14H24N4 | 248.37 | | |
| 34 | 583811-50-1 | Pyrazolo[3,4-b]azepine, 3-(2-benzofuranyl)-1,4,5,6,7,8-hexahydro-1-methyl- (9CI) | C16H17N3O | 267.33 | | |
| 35 | 583811-53-4 | Pyrazolo[3,4-b]azepine, 1-ethyl-1,4,5,6,7,8-hexahydro-3-propyl- (9CI) | C12H21N3 | 207.32 | | |
| 36 | 583811-55-6 | Pyrazolo[3,4-b]azepine, 1-ethyl-1,4,5,6,7,8-hexahydro-3-[(methylthio)methyl]- (9CI) | C11H19N3S | 225.35 | | |
| 37 | 583811-64-7 | Pyrazolo[3,4-b]azepine, 3-(1,1-dimethylethyl)-1-ethyl-1,4,5,6,7,8-hexahydro- (9CI) | C13H23N3 | 221.34 | | |
| 38 | 583811-70-5 | Pyrazolo[3,4-b]azepine, 1-ethyl-1,4,5,6,7,8-hexahydro-3-(2-methylpropyl)- (9CI) | C13H23N3 | 221.34 | | |
| 39 | 583811-72-7 | Pyrazolo[3,4-b]azepine, 1-ethyl-1,4,5,6,7,8-hexahydro-3-(1-methylethyl)- (9CI) | C12H21N3 | 207.32 | | |
| 40 | 583811-73-8 | Pyrazolo[3,4-b]azepine, 1-ethyl-1,4,5,6,7,8-hexahydro-3-(methoxymethyl)- (9CI) | C11H19N3O | 209.29 | | |
| 41 | 583811-95-4 | Pyrazolo[3,4-b]azepine, 3-butyl-1-ethyl-1,4,5,6,7,8-hexahydro- (9CI) | C13H23N3 | 221.34 | | |
| 42 | 583812-38-8 | Pyrazolo[3,4-b]azepine, 3-cyclobutyl-1-ethyl-1,4,5,6,7,8-hexahydro- (9CI) | C13H21N3 | 219.33 | | |
| 43 | 583812-51-5 | Pyrazolo[3,4-b]azepine, 3-(2-benzofuranyl)-1-ethyl-1,4,5,6,7,8-hexahydro- (9CI) | C17H19N3O | 281.35 | | |
| 44 | 583812-69-5 | Pyrazolo[3,4-b]azepine-1(4H)-carboxamide, 3-ethyl-5,6,7,8-tetrahydro- (9CI) | C10H16N4O | 208.26 | | |
| 45 | 583814-96-4 | 1-METHYLPIPERIDIN-3-YL METHANESULFONATE | C7H15NO3S | 193.26 | | |
| 46 | 583815-75-2 | 6-{4-[(2,4-dichlorobenzyl)oxy]-3-iodo-5-methoxybenzylidene}-5-imino-3-phenyl-5,6-dihydro-7H-[1,3]thiazolo[3,2-a]pyrimidin-7-one | C27H18Cl2IN3O3S | 662.32559 | | |
| 47 | 583817-77-0 | 5-[3-bromo-5-methoxy-4-(prop-2-ynyloxy)benzylidene]-1-methyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione | C16H13BrN2O4S | 409.25442 | | |
| 48 | 583819-80-1 | ethyl [5-(2,4-dichlorobenzylidene)-2,4-dioxo-1,3-thiazolidin-3-yl]acetate | C14H11Cl2NO4S | 360.21 | | |
| 49 | 58382-91-5 | poly(2-aminoadenylic acid)-poly U | C19H28N8O16P2 | 686.42 | | |
| 50 | 583823-94-3 | 3-Amino-3-methylbutanoic acid hydrochloride | C5H12ClNO2 | 153.61 | | |
| 51 | 583823-98-7 | 2-Imidazolidinone 1-acetyl-, 4,4,5,5-tetramethyl- (7CI) | C9H16N2O2 | 184.24 | | |
| 52 | 583823-99-8 | 2-Imidazolidinone 1-acetyl-, 4,4-dimethyl- (7CI) | C7H12N2O2 | | | |
| 53 | 583825-29-0 | 1-(3-Azidopropyl)-4-methoxybenzene | C10H13N3O | 191.23 | | |
| 54 | 583825-30-3 | 4-(3-aminopropyl)phenol hydrobromide | C9H14BrNO | 232.12 | | |
| 55 | 583827-06-9 | (3S,4S)-4-[(1R)-Phenylethylamino-3-methoxycarbonyl]-2,2,6,6-tetramethylpiperidine-1-oxyl Hydrochlori | C19H30ClN2O3 | 369.91 | | |
| 56 | 583827-08-1 | (3R,4R)-4-[(1S)-Phenylethylamino-3-methoxycarbonyl]-2,2,6,6-tetramethylpiperidine-1-oxyl Hydrochlori | C19H30ClN2O3 | 369.91 | | |
| 57 | 583827-12-7 | Fmoc-(3S,4S)-4-amino-1-oxyl-2,2,6,6-tetramethylpiperidine-3-carboxylic Acid | C25H29N2O5 | 437.51 | | |
| 58 | 583827-13-8 | Fmoc-(3R,4R)-4-amino-1-oxyl-2,2,6,6-tetramethylpiperidine-3-carboxylic Acid | C25H29N2O5 | 437.51 | | |
| 59 | 583829-58-7 | 2,7-Bis(4-aMino-2-trifluoroMethylph-enoxy)naphthalene | C24H16F6N2O2 | 478.3864592 | | |
| 60 | 58383-30-5 | Homoserine, O-(2-aminoethyl)- | C6H14N2O3 | 162.19 | | |
| 61 | 58383-35-0 | (+)-2,3-O-BENZYLIDENE-D-THREITOL | C11H14O4 | 210.23 | 70-72°C(lit.) | |
| 62 | 58383-61-2 | 15-hydroxyandrostenedione | C19H26O3 | 302.41 | | |
| 63 | 58383-76-9 | Dezocine Impurity | | | | |
| 64 | 58383-80-5 | 5,11-Methanobenzocyclodecen-3-ol, 13-amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-, hydrobromide, [5S-(5α,11α,13S*)]- | C16H23NO.BrH | 326.27 | | |
| 65 | 58383-82-7 | 5,11-Methanobenzocyclodecen-13-amine, 5,6,7,8,9,10,11,12-octahydro-3-methoxy-5-methyl-, (5S,11R,13R)- | C17H25NO | 259.39 | | |
| 66 | 58383-94-1 | (25R)-5α-Spirostane-2α,3β,6α-triol | C27H44O5 | 448.64 | | |
| 67 | 583830-09-5 | {[(3-methylidenecyclobutyl)methoxy]methyl}benzene | C13H16O | 188.27 | | |
| 68 | 583832-09-1 | 1(2H)-Isoquinolinone, 6-broMo-2-(cyclohexylMethyl)-3-(hydroxyMethyl)-4-phenyl- | C23H24BrNO2 | 426.34616 | | |
| 69 | 583832-85-3 | 3-Isoquinolinecarboxylic acid, 6-broMo-1,2-dihydro-2-[[4-(Methylsulfonyl)phenyl]Methyl]-1-oxo-4-phenyl-, Methyl ester | C25H20BrNO5S | 526.4 | | |
| 70 | 583836-55-9 | (Cys46)-HIV-1 tat Protein (46-57) amide trifluoroacetate salt H-Cys-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2 trifluoroacetate salt | C67H124N34O14S | 1661.99 | | |
| 71 | 583837-94-9 | [4-(Ethanesulphonyl)phenyl]methanamine | C9H13NO2S | 199.27 | | |
| 72 | 58384-41-1 | Propanoic acid, 3,3'-[(2-hydroxy-1,1-dimethylethyl)imino]bis[2,2-dimethyl-, diethyl ester (9CI) | C18H35NO5 | 345.47 | | |
| 73 | 58384-57-9 | 1,2-Dithiolane, 3,3-dimethyl- | C5H10S2 | 134.26 | | |
| 74 | 583840-03-3 | Sorafenib N-Oxide | C21H16ClF3N4O4 | 480.82 | 220-222oC | |
| 75 | 583840-04-4 | Sorafenib Impurity 13 | C20H14ClF3N4O4 | 466.8 | | |
| 76 | 583844-38-6 | ((4S,5S)-(-)-O-[1-BENZYL-1-(5-METHYL-2-PHENYL-4,5-DIHYDROOXAZOL-4-YL)-2-PHENYLETHYL]-DICYCLOHEXYL-PHOSPHINITE)(1,5-COD)IRIDIUM (I) TETRAKIS(3,5-BIS(TRIFLUOROMETHYL)PHENYLBORATE | | | | |
| 77 | 583845-23-2 | Pyrrolo[1,2-d][1,2,4]triazine-1,4-dione, hexahydro-, (8aS)- (9CI) | C6H9N3O2 | 155.15 | | |
| 78 | 583853-02-5 | ethyl (5-{[1-(2-fluorobenzyl)-1H-indol-3-yl]methylene}-2,4-dioxo-1,3-thiazolidin-3-yl)acetate | C23H19FN2O4S | 438.47 | | |
| 79 | 583853-15-0 | N'-{4-[(2,6-dichlorobenzyl)oxy]-3-iodo-5-methoxybenzylidene}isonicotinohydrazide | C21H16Cl2IN3O3 | 556.18051 | | |
| 80 | 58386-00-8 | (5-methoxy-2-thienyl)thioacetic acid | C7H8O3S2 | 204.27 | | |
| 81 | 58386-20-2 | 2,5-DIMETHOXYTHIOPHENE | C6H8O2S | 144.19 | | |
| 82 | 58386-33-7 | 1-PHENYL-1H-INDOLE-2-CARBOXYLIC ACID | C15H11NO2 | 237.25 | | |
| 83 | 583860-52-0 | CHEMBRDG-BB 5785240 | C10H10O4 | 194.18 | | |
| 84 | 583860-78-0 | 2-bromo-1-(5-bromo-1-naphthalenyl)ethanone | C12H8Br2O | 328 | | |
| 85 | 583861-17-0 | Carbamic acid, (4,5-dihydro-5-methyl-4-oxo-2-oxazolyl)-, 1,1-dimethylethyl | C9H14N2O4 | 214.22 | | |
| 86 | 583868-50-2 | MOL-6131 | C43H48N8O5 | 756.89 | | |
| 87 | 583870-09-1 | BOC-D-PHE(4-NHBOC)-OH | C19H28N2O6 | 380.44 | | |
| 88 | 583870-83-1 | 4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclohexane-1-carboxylic acid | C22H23NO4 | 365.42 | | |
| 89 | 583871-11-8 | 5,8-Iminoquinoline,5,6,7,8-tetrahydro-9-methyl-(9CI) | C10H12N2 | 160.22 | | |
| 90 | 583871-31-2 | 1-(4-METHYLPHENYL)-6,7-DIMETHOXY-3,4-DIHYDROISOQUINOLINE | C18H19NO2 | | | |
| 91 | 583878-42-6 | Ethyl 4-chloro-6-methyl-2-(methylthio)pyrimidine-5-carboxylate | C9H11ClN2O2S | 246.71 | | |
| 92 | 583879-18-9 | 1H-Imidazole,1-ethyl-2-[(1E)-phenylazo]-(9CI) | C11H12N4 | 200.24 | | |
| 93 | 583879-19-0 | 1H-Imidazole,1-ethyl-2-[(1E)-(4-methylphenyl)azo]-(9CI) | C12H14N4 | 214.27 | | |
| 94 | 583880-92-6 | methyl 6-fluoro-1-oxo-1,2-dihydroisoquinoline-4-carboxylate | C11H8FNO3 | 221.18 | | |
| 95 | 583880-95-9 | 2-(Carboxymethyl)-5-fluorobenzoic acid | C9H7FO4 | 198.15 | | |
| 96 | 583881-07-6 | 2-(carboxymethyl)-6-fluorobenzoic acid | C9H7FO4 | 198.15 | | |
| 97 | 583883-61-8 | 5-Pyrimidinecarbonyl chloride, 1,2-dihydro-4-methyl-2-oxo- (9CI) | C6H5ClN2O2 | 172.57 | | |
| 98 | 583883-82-3 | METHYL 4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-OXAZOLE-5-CARBOXYLATE | C13H10F3NO3 | 285.22 | | |
| 99 | 583883-84-5 | Acetic acid, 2-[4-[(dimethylamino)thioxomethoxy]-2-methylphenoxy]-, methyl ester | C13H17NO4S | 283.34 | | |
| 100 | 583883-85-6 | Acetic acid, 2-[4-[[(dimethylamino)carbonyl]thio]-2-methylphenoxy]-, methyl ester | C13H17NO4S | 283.34 | | |
| 101 | 583884-12-2 | 2,2'-Bithiophene, 5,5'-bis(4-hexylphenyl)- | C32H38S2 | 486.77 | | |
| 102 | 583884-13-3 | 2,2':5',2''-Terthiophene, 5,5''-bis(4-hexylphenyl)- (9CI) | C36H40S3 | 568.9 | | |
| 103 | 583886-76-4 | Propanamide, N,N-diethyl-2,2-difluoro- (9CI) | C7H13F2NO | 165.18 | | |
| 104 | 58389-65-4 | Acetamide, N-hydroxy-2-(phosphonooxy)-, compd. with cyclohexanamine (1:2) | C8H19N2O6P | 270.22 | | |